Yüklüyor......
Pharmacogenetic Optimization of Smoking Cessation Treatment
Worldwide, approximately one billion people smoke cigarettes. Cigarette smoking persists in part because long-term smoking cessation rates are modest on existing treatments. Smoking cessation outcomes are influenced by genetic factors, including genetic variation in enzymes that metabolize nicotine...
Kaydedildi:
| Yayımlandı: | Trends Pharmacol Sci |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5195866/ https://ncbi.nlm.nih.gov/pubmed/27712845 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tips.2016.09.006 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|